OBIO Bear Put Spread Strategy

OBIO (Orchestra BioMed Holdings, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

OBIO (Orchestra BioMed Holdings, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $237.6M, a beta of 0.52 versus the broader market, a 52-week range of 2.2-5.424, average daily share volume of 202K, a public-listing history dating back to 2020, approximately 70 full-time employees. These structural characteristics shape how OBIO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.52 indicates OBIO has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a bear put spread on OBIO?

A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.

Current OBIO snapshot

As of May 15, 2026, spot at $3.78, ATM IV 99.00%, IV rank 21.73%, expected move 28.38%. The bear put spread on OBIO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this bear put spread structure on OBIO specifically: OBIO IV at 99.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a OBIO bear put spread, with a market-implied 1-standard-deviation move of approximately 28.38% (roughly $1.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OBIO expiries trade a higher absolute premium for lower per-day decay. Position sizing on OBIO should anchor to the underlying notional of $3.78 per share and to the trader's directional view on OBIO stock.

OBIO bear put spread setup

The OBIO bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OBIO near $3.78, the first option leg uses a $3.78 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OBIO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OBIO shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Put	$3.78	N/A
Sell 1	Put	$3.59	N/A

OBIO bear put spread risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.

OBIO bear put spread payoff curve

Modeled P&L at expiration across a range of underlying prices for the bear put spread on OBIO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use bear put spread on OBIO

Bear put spreads on OBIO reduce the cost of a bearish OBIO stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.

OBIO thesis for this bear put spread

The market-implied 1-standard-deviation range for OBIO extends from approximately $2.71 on the downside to $4.85 on the upside. A OBIO bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on OBIO, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current OBIO IV rank near 21.73% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OBIO at 99.00%. As a Healthcare name, OBIO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OBIO-specific events.

OBIO bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OBIO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OBIO alongside the broader basket even when OBIO-specific fundamentals are unchanged. Long-premium structures like a bear put spread on OBIO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current OBIO chain quotes before placing a trade.

Frequently asked questions

What is a bear put spread on OBIO?: A bear put spread on OBIO is the bear put spread strategy applied to OBIO (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With OBIO stock trading near $3.78, the strikes shown on this page are snapped to the nearest listed OBIO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are OBIO bear put spread max profit and max loss calculated?: Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the OBIO bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 99.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a OBIO bear put spread?: The breakeven for the OBIO bear put spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OBIO market-implied 1-standard-deviation expected move is approximately 28.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a bear put spread on OBIO?: Bear put spreads on OBIO reduce the cost of a bearish OBIO stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
How does current OBIO implied volatility affect this bear put spread?: OBIO ATM IV is at 99.00% with IV rank near 21.73%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.